Entera Bio Ltd (ENTX)

0.887 +0.038 (+4.44%)
Closed USD Disclaimer
0.923 +0.036 (+4.000%)

Entera Bio Ltd Company Profile

Sector
Healthcare
Employees
22
Equity Type
ORD
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Contact Information
Address
Jerusalem,9112002 Israel
Phone
972 2 532 7151
Fax
-
Top Executives
Name
Age
Since
Title
Gerald M. Lieberman 75 2014 Independent Chairman of the Board
Yonatan Malca 56 2011 Independent Director
Gerald M. Ostrov 73 2019 Independent Director
Ron Mayron 59 2021 Independent Director
Sean Ellis 47 2019 Independent Director
Miranda J. Toledano 45 2018 CEO & Director
Socrates Papapoulos 0 2022 Member of Scientific Advisory Board
Roger J. Garceau 69 2016 Director
Steven R. Goldstein 72 2023 Member of Clinical & Scientific Advisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.